Inventor · Cambridge, MA, US

Jean-Pierre Sommadossi

81Patents
31h-index
26Co-inventors
88Inventor score

Filing activity: Apr 12, 1988 → Jul 24, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US7105493B2 Methods and compositions for treating flaviviruses and pestiviruses Emerging Cross-Sectional Technologies 179 Expired
US6914054B2 Methods and compositions for treating hepatitis C virus Physics 168 Expired
US7608597B2 Methods and compositions for treating hepatitis C virus Physics 153 Expired
US6812219B2 Methods and compositions for treating flaviviruses and pestiviruses Emerging Cross-Sectional Technologies 147 Expired
US7608600B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 144 Expired
US7148206B2 Methods and compositions for treating flaviviruses and pestiviruses Emerging Cross-Sectional Technologies 126 Expired
US7163929B2 Methods and compositions for treating flaviviruses and pestiviruses Emerging Cross-Sectional Technologies 123 Expired
US7169766B2 Methods and compositions for treating hepatitis C virus Physics 101 Expired
US7365057B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flavivridae infections Chemistry; Metallurgy 95 Expired
US7635689B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 93 Expired
US7157441B2 Methods and compositions for treating hepatitis C virus Physics 93 Expired
US6787526B1 Methods of treating hepatitis delta virus infection with &bgr;-L-2′-deoxy-nucleosides Chemistry; Metallurgy 81 Expired
US5118672A 5'-diphosphohexose nucleoside pharmaceutical compositions Chemistry; Metallurgy 69 Expired
US7951789B2 Compounds and pharmaceutical compositions for the treatment of viral infections Chemistry; Metallurgy 69 Active
US7625875B2 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Human Necessities 67 Expired
US7547704B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 64 Expired
US7456155B2 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections Human Necessities 64 Expired
US7138376B2 Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides Chemistry; Metallurgy 61 Expired
US7192936B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 61 Expired
US7902202B2 Compounds and pharmaceutical compositions for the treatment of viral infections Chemistry; Metallurgy 60 Active
US7384924B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 59 Expired
US7582618B2 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections Human Necessities 58 Active
US7101861B2 Methods and compositions for treating flaviviruses and pestiviruses Emerging Cross-Sectional Technologies 56 Expired
US7662798B2 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Human Necessities 55 Expired
US7824851B2 2′-branched nucleosides and Flaviviridae mutation Emerging Cross-Sectional Technologies 54 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.